Awards & Advancement

Davita Clinical Research hires four

Monday, August 20, 2012 02:33 PM

DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney research, has hired four individuals to ignite the expansion of DCR at its latest clinical research facility in Denver, Colo. The new team members include: Dr. Christopher Galloway, medical director; Chad Jaeger, senior director of clinical operations; Amy Denvir, director of operations-Denver; and Michael Kreuter, director of data management.

More... »

CROS NT appoints MacGarvey as vice president

Wednesday, August 15, 2012 02:01 PM

CROS NT, an international CRO specializing in clinical data services, has appointed Andrew MacGarvey as the vice president of U.K. and U.S. operations.

More... »

Peter Alterman named COO of SAFE-BioPharma

Monday, August 13, 2012 03:13 PM

Peter Alterman, Ph.D., who held numerous senior information security positions within the U.S. federal government, has been named chief operating officer of SAFE-BioPharma Association, the strategic, non-profit collaboration responsible for the global SAFE-BioPharma digital identity and digital signature standard used in the life science and healthcare sectors.
 
Alterman recently retired after 33 years of government service where, most recently, he was senior advisor to the national program office of the National Strategy for Trusted Identities in Cyberspace (NSTIC), NIST. Before that he served as senior advisor to the NIH CIO for Strategic Initiatives, Assistant CIO for e-authentication at the National Institutes of Health and chair of the U.S. Federal PKI Policy Authority. His role in Internet technology started in 1989 as a member of the Federal Research Internet Coordinating Committee.
  
In addition to responsibilities for a variety of association management functions, Alterman will serve as SAFE-BioPharma’s primary liaison with the FDA and other global regulatory authorities and represent the association’s interests on global standards and policy bodies.

More... »

PAREXEL International announces CFO transition

Friday, August 10, 2012 02:11 PM

PAREXEL International, a global bio/pharmaceutical services organization, announced that James F. Winschel, Jr., senior vice president and CFO, will transition to the position of executive vice president at PAREXEL upon appointment of a new CFO. 

More... »

Nile Therapeutics promotes Horton to president, CEO, director

Thursday, August 9, 2012 03:06 PM

Nile Therapeutics, a San Mateo, Calif.-based biopharmaceutical company that develops novel therapeutics for heart failure, has promoted Darlene Horton, M.D. to president, CEO and director of the company.

More... »

PAREXEL appoints Larson as VP of evidence development

Friday, August 3, 2012 12:25 PM

PAREXEL Consulting, a business unit of PAREXEL International and a global consultancy serving the biopharmaceutical and medical device industries, has appointed Leanne R. Larson as vice president of evidence development, a newly created position.

More... »

UTEP science program receives $4.2M grant from NIH

Friday, August 3, 2012 11:43 AM

The Research Initiative for Scientific Enhancement (RISE) program at The University of Texas, El Paso, has been awarded a five-year grant from the National Institutes of Health (NIH) totaling more than $4.2 million , funding student research training initiatives until 2017.

More... »

Teva appoints two to executive team

Friday, August 3, 2012 11:07 AM

Teva Pharmaceutical, a global pharmaceutical company based in Israel, has appointed Dr. Carlo De Notaristefani as president and CEO of global operations and Aharon (Arik) Yaari as executive vice president of newly created community and institutional affairs.

More... »

RxAlly adds Mike Groh as CIO

Thursday, August 2, 2012 03:33 PM

RxAlly, an alliance of more than 22,000 pharmacies nationwide, has appointed Michael J. Groh, PharmD, as chief information officer.

More... »

Endocyte appoints Novartis vet David Meek as chief commercial officer

Monday, July 30, 2012 03:49 PM

Endocyte, an Indianapolis, Ind.-based biopharmaceutical company focused on cancer and inflammatory diseases, has appointed David Meek to the newly created position of chief commercial officer. He will be responsible for the development of Endocyte’s commercial team and overall commercial strategy and execution.

More... »